CME Group Company Profile (NASDAQ:CME)

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group declared a quarterly dividend on Tuesday, May 23rd. Investors of record on Friday, June 9th will be paid a dividend of $0.66 per share on Monday, June 26th. This represents a $2.64 annualized dividend and a yield of 2.18%. The ex-dividend date is Wednesday, June 7th. View CME Group's Dividend History.

CME Group Inc. (NASDAQ:CME) posted its quarterly earnings results on Thursday, April, 27th. The company reported $1.22 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.20 by $0.02. The business had revenue of $929 million for the quarter, compared to analyst estimates of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. The company's revenue was down .5% on a year-over-year basis. During the same quarter last year, the business earned $1.15 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for CME Group.

7 analysts have issued 12 month price objectives for CME Group's shares. Their forecasts range from $99.00 to $140.00. On average, they anticipate CME Group's share price to reach $126.71 in the next year. View Analyst Ratings for CME Group.

Here are some recent quotes from research analysts about CME Group stock:

• 1. According to Zacks Investment Research, "Shares of the CME Group underperformed the Zacks categorized Securities Exchanges industry year to date. The company has also been witnessing estimates moving south over the last 60 days. Mounting expenses remain a concern. It projects higher expense in 2017 and license fees to increase in the 10-15% band year over year.  Exposure to interest rate volatility, limited credit availability can hamper liquidity. Nonetheless, CME Group remains well positioned for growth on the back of its strong market position with diverse derivative product lines. Efforts to expand and cross sell its core exchange-traded business through new product initiatives and global reach also support growth. CME is set to report second quarter results on Aug 1. Our proven model cannot conclusively say if it will beat or miss expectation as Zacks Rank #4 that lower the predictive power  of a beat when combined with Earnings ESP of 0.00% makes prediction difficult." (7/11/2017)
• 2. J P Morgan Chase & Co analysts commented, "CME reported GAAP EPS of $0.95 and Adjusted EPS of $1.14. Revenue was a bit lower than expected on product RPC even though the mix generally improved for the quarter. Expenses were also lower, particularly comp. CME has a lot going on in product development and will invest more to bring a number of products to market. While we feel such investments are critical, we also feel that investors will only pay for them after-the-fact, rather than before. We continue to think of CME as a true income-growth investment idea and thus maintain the Overweight rating." (7/29/2016)

Some companies that are related to CME Group include American Express Company (AXP), Bank of Nova Scotia (The) (BNS), ING Group, N.V. (ING), BlackRock (BLK), Axa SA (AXAHY), Australia & New Zealand Banking Group (ANZBY), D/B/A Chubb Limited New (CB), UBS AG (UBS), National Australia Bank (NABZY), Prudential Public Limited Company (PUK), PNC Financial Services Group, Inc. (The) (PNC), Intesa Sanpaolo SpA (ISNPY), American International Group (AIG), MetLife (MET), American Tower Corporation (REIT) (AMT), Banco Bradesco SA (BBD), The Charles Schwab Corporation (SCHW) and PowerShares QQQ Trust, Series 1 (QQQ).

CME Group's management team includes the folowing people:

• Terrence A. Duffy, Executive Chairman of the Board, Chief Executive Officer
• Bryan T. Durkin, President
• Charles Peter Carey, Vice Chairman of the Board
• John W. Pietrowhicz CPA, Chief Financial Officer
• Sunil Cutinho, President - CME Clearing
• Kimberly S. Taylor, President - Clearing and Post-Trade Services
• Hilda Harris Piell, Chief Human Resource Officer, Senior Managing Director
• Jack J. Tobin, Chief Accounting Officer
• Kevin Kometer, Chief Information Officer, Senior Managing Director
• Kathleen M. Cronin, Senior Managing Director, General Counsel, Corporate Secretary

CME Group's stock is owned by a variety of of institutional and retail investors. Top institutional investors include APG Asset Management N.V. (0.54%), Chevy Chase Trust Holdings Inc. (0.18%), Forsta AP Fonden (0.13%), Intermede Investment Partners Ltd (0.12%), Bank of Montreal Can (0.11%) and US Bancorp DE (0.08%). Company insiders that own CME Group stock include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, James E Oliff, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Robert Zagotta, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME Group's stock was sold by a variety of institutional investors in the last quarter, including Forsta AP Fonden, APG Asset Management N.V., NN Investment Partners Holdings N.V., Vontobel Asset Management Inc., Exxonmobil Investment Management Inc. TX, LS Investment Advisors LLC, Cullinan Associates Inc. and Capital One National Association. Company insiders that have sold CME Group stock in the last year include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME Group's stock was bought by a variety of institutional investors in the last quarter, including Intermede Investment Partners Ltd, Mn Services Vermogensbeheer B.V., Opera Trading Capital, National Pension Service, Gateway Investment Advisers LLC, Guinness Asset Management Ltd, Aperio Group LLC and Chevy Chase Trust Holdings Inc.. View Insider Buying and Selling for CME Group.

Shares of CME Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME Group stock can currently be purchased for approximately $121.00.